Taming the fear: can a new therapy quiet the worry of advanced cancer?
NCT ID NCT05679518
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This trial tests whether a structured talk therapy called ConquerFear can help people with advanced cancer manage their fear of the disease progressing. It compares ConquerFear to a supportive-expressive approach, which focuses on emotional expression and support. The study involves Chinese-speaking adults recently diagnosed with stage III or IV cancer. The goal is to see if ConquerFear reduces fear of progression and improves emotional well-being.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ConquerFear, a structured talk therapy that helps people manage worry and fear about cancer progression
- What this could lead to
- If effective, this could offer a practical, non-drug way to ease the emotional burden of advanced cancer, improving quality of life.
- What could go wrong
- The trial is relatively small and results may not apply to all cancer patients. Talk therapy requires commitment and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Queen Mary Hospital-Department of Obstetrics & Gynaecology
RECRUITINGHong Kong, Hong Kong
-
Queen Mary Hospital-Department of Oncology
NOT_YET_RECRUITINGHong Kong, Hong Kong
-
Queen Mary Hospital-Department of Surgery
RECRUITINGHong Kong, Hong Kong
-
Tung Wah Hospital-Department of Surgery
NOT_YET_RECRUITINGHong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.